Etripamil nasal spray (Milestone Pharmaceuticals) continues to show promise as a way for patients to treat their own paroxysmal supraventricular tachycardia (PSVT) without the need for an emergency ...
As Healio previously reported, in the main results of NODE-301, etripamil (Millstone Pharmaceuticals), an L-type calcium channel blocker administered via nasal spray, missed the primary endpoint of ...
Please provide your email address to receive an email when new articles are posted on . Etripamil, a novel fast-acting calcium channel blocker administered via nasal spray, was not superior to placebo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback